BOULDER, Colo., May 2 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) will report financial results for the third quarter of fiscal
2005 on Monday, May 9, 2005, at 4:30 p.m. eastern time and hold a conference
call on Tuesday, May 10, 2005, at 9:00 a.m. eastern time. Robert E. Conway,
Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will
lead the call.
Conference Call Information
Date: Tuesday, May 10, 2005
Time: 9:00 a.m. eastern time
Toll-Free: (800) 478-6251
Toll: (913) 981-5558
Pass Code: 4484757
Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be
accessed in the United States by dialing toll-free (888) 203-1112, and outside
the United States (719) 457-0820. The access code is 4484757. Replay of the
call will also be available as a web cast on Array's web site at
Array BioPharma is a biopharmaceutical company focused on the discovery,
development and commercialization of orally active drugs to address
significant unmet medical needs. Our proprietary drug development pipeline is
primarily focused on the treatment of cancer and inflammatory disease and
includes several small molecule drug candidates that are designed to regulate
targets in therapeutically important biologic pathways. In addition, leading
pharmaceutical and biotechnology companies access our drug discovery
technologies and expertise through collaborations to design, create, optimize
and evaluate drug candidates across a broad range of therapeutic areas. For
more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc.,
Web site: http://www.arraybiopharma.com